MTOR and breast carcinoma: Dysregulation of these functions belongs to the disease characteristics of cancer and the PI3K/AKT/mTOR pathway has been identified as a key player driving carcinogenesis in various tumor entities such as breast cancer and renal cell carcinoma [23].